Serviços Personalizados
Journal
Artigo
Indicadores
- Citado por SciELO
- Acessos
Links relacionados
- Citado por Google
- Similares em SciELO
- Similares em Google
Compartilhar
Revista Colombiana de Reumatología
versão impressa ISSN 0121-8123
Resumo
PINEROS CASTILLO, Joaquín Arturo; AREVALO ROA, Helbert Orlando e MUNOZ-GALINDO, Iván Mauricio. Management results of a cohort of rheumatoid arthritis patients in a specialized comprehensive healthcare institution in Colombia. Rev.Colomb.Reumatol. [online]. 2022, vol.29, n.2, pp.93-100. Epub 21-Fev-2023. ISSN 0121-8123. https://doi.org/10.1016/j.rcreu.2021.01.009.
Objective:
To determine the management results in a cohort of patients with rheumatoid arthritis in a specialized integral healthcare institution for this disease in Colombia.
Materials and methods:
Descriptive cross-sectional study based on a cohort of rheumatoid arthritis patients according to ACR/EULAR 2010 criteria. The information was analysed based on consolidated data from clinical records and national reports in the period 2015-2018. Administrative records related to medication authorizations and prescriptions were considered. Sociodemographic variables, outcome indicators related to disease activity status and medication use percentage were evaluated.
Results:
As of June 30th 2018, 698 patients were identified, of which the female sex represented 83.8%, the general average age was 55.47 years, and the highest number of cases were in the 60-64 year age group. Of the patients, 68.3% were between remission and low disease activity. Seventy-three point one percent were managed with conventional disease-modifying antirheumatic drugs and a reduction in the use of biological therapy was recorded from 27.2% in 2016 to 17.8% at the end of the period.
Conclusions:
This study presents the management results of a comprehensive care model for patients with rheumatoid arthritis in Colombia, which managed to maintain the highest proportion of patients in low activity and remission as they had a longer follow-up time, to decrease the percentage of biological DMARDs use, and establish conventional DMARDs as the main therapeutic alternative.
Palavras-chave : Rheumatoid arthritis; Antirheumatic agents; Healthcare programmes; Outcome assessment.